Law ❯ Litigation

Securities Law

Class Action Investor Rights Fraud Class Action Lawsuits Shareholder Rights Corporate Law Investor Protection Class Actions Corporate Governance Regulatory Compliance

NuScale Investors Face April 20 Deadline in Securities Suit Over ENTRA1 Claims

The complaint says NuScale misled investors about ENTRA1’s experience, citing a $495 million payment disclosure that preceded share losses.

Jury Finds Elon Musk Liable for Misleading Twitter Shareholders With 2022 Tweets

Gemini, Winklevoss Twins Face Investor Class Actions Over IPO Disclosures After Strategy Pivot

Jury Finds Elon Musk Liable for Misleading Twitter Shareholders With 2022 Tweets

Lakeland Industries Investors Face April 24 Deadline to Seek Lead Role in Securities Class Action

Plaintiff Firms Step Up uniQure Solicitation After FDA Rebuke, With April 13 Lead-Plaintiff Deadline

Corcept Faces Securities Class Action Over Relacorilant Disclosures as Firms Rally Investors Before April 21 Deadline

Trip.com Faces U.S. Investor Lawsuits After Disclosing Chinese Antitrust Probe

Stories older than 24h

Law Firms Mobilize Investors in Eos Energy Securities Suit as May 5 Deadline Nears

Richtech Robotics Investor Suits Seek Lead Plaintiff Ahead of April 3 Deadline

Hagens Berman Files Securities Class Action Against PayPal Over 'Branded Checkout' Claims

Law Firms Announce Securities Class Actions for ODDITY Tech and ChowChow With May Lead‑Plaintiff Deadlines

Navan Faces Securities Class Action Over IPO Disclosures as Lead-Plaintiff Push Builds

Apollo Investors Get Chance to Lead Securities Class Action Over Epstein Claims

Kyndryl Investors Face April 13 Deadline to Seek Lead Role in Expanding Securities Class Actions

Gartner Securities Class Action Spurs Race for Lead Plaintiff Before May 18

Enphase Securities Case Heats Up as Firms Push Lead-Plaintiff Bids Before April 20 Deadline

Alight Investors Get May 15 Deadline To Seek Lead Plaintiff Role in Securities Class Action

Rosen Files Trip.com Securities Class Action as Schall Seeks Investors for Parallel Effort

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety and Launch Claims